Logo image of OPRA

OPERA LTD-ADR (OPRA) Stock Fundamental Analysis

NASDAQ:OPRA - Nasdaq - US68373M1071 - ADR - Currency: USD

18.9  +0.43 (+2.33%)

After market: 19.02 +0.12 (+0.63%)

Fundamental Rating

7

Overall OPRA gets a fundamental rating of 7 out of 10. We evaluated OPRA against 282 industry peers in the Software industry. OPRA is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. An interesting combination arises when we look at growth and value: OPRA is growing strongly while it also seems undervalued. These ratings would make OPRA suitable for value and growth investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year OPRA was profitable.
In the past year OPRA had a positive cash flow from operations.
Of the past 5 years OPRA 4 years were profitable.
OPRA had a positive operating cash flow in each of the past 5 years.
OPRA Yearly Net Income VS EBIT VS OCF VS FCFOPRA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

1.2 Ratios

The Return On Assets of OPRA (8.07%) is better than 82.62% of its industry peers.
OPRA's Return On Equity of 9.06% is fine compared to the rest of the industry. OPRA outperforms 76.95% of its industry peers.
OPRA has a better Return On Invested Capital (8.93%) than 84.75% of its industry peers.
OPRA had an Average Return On Invested Capital over the past 3 years of 6.40%. This is significantly below the industry average of 12.26%.
The 3 year average ROIC (6.40%) for OPRA is below the current ROIC(8.93%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 8.07%
ROE 9.06%
ROIC 8.93%
ROA(3y)8.12%
ROA(5y)7.3%
ROE(3y)8.98%
ROE(5y)7.94%
ROIC(3y)6.4%
ROIC(5y)N/A
OPRA Yearly ROA, ROE, ROICOPRA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

OPRA has a Profit Margin of 16.09%. This is amongst the best in the industry. OPRA outperforms 82.62% of its industry peers.
In the last couple of years the Profit Margin of OPRA has declined.
OPRA has a better Operating Margin (18.07%) than 85.46% of its industry peers.
OPRA has a Gross Margin of 69.58%. This is comparable to the rest of the industry: OPRA outperforms 52.48% of its industry peers.
In the last couple of years the Gross Margin of OPRA has declined.
Industry RankSector Rank
OM 18.07%
PM (TTM) 16.09%
GM 69.58%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y-12.55%
GM growth 3Y-8.45%
GM growth 5Y-5.94%
OPRA Yearly Profit, Operating, Gross MarginsOPRA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80 100

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so OPRA is destroying value.
OPRA has more shares outstanding than it did 1 year ago.
OPRA has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, OPRA has an improved debt to assets ratio.
OPRA Yearly Shares OutstandingOPRA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
OPRA Yearly Total Debt VS Total AssetsOPRA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

OPRA has an Altman-Z score of 10.43. This indicates that OPRA is financially healthy and has little risk of bankruptcy at the moment.
OPRA's Altman-Z score of 10.43 is amongst the best of the industry. OPRA outperforms 85.82% of its industry peers.
The Debt to FCF ratio of OPRA is 0.11, which is an excellent value as it means it would take OPRA, only 0.11 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of OPRA (0.11) is better than 81.56% of its industry peers.
OPRA has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.01, OPRA is doing good in the industry, outperforming 66.31% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.11
Altman-Z 10.43
ROIC/WACC0.98
WACC9.1%
OPRA Yearly LT Debt VS Equity VS FCFOPRA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 2.17 indicates that OPRA has no problem at all paying its short term obligations.
The Current ratio of OPRA (2.17) is better than 65.25% of its industry peers.
OPRA has a Quick Ratio of 2.17. This indicates that OPRA is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of OPRA (2.17) is better than 65.60% of its industry peers.
Industry RankSector Rank
Current Ratio 2.17
Quick Ratio 2.17
OPRA Yearly Current Assets VS Current LiabilitesOPRA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

7

3. Growth

3.1 Past

The earnings per share for OPRA have decreased strongly by -46.43% in the last year.
The Earnings Per Share has been growing by 29.22% on average over the past years. This is a very strong growth
The Revenue has grown by 26.91% in the past year. This is a very strong growth!
Measured over the past years, OPRA shows a very strong growth in Revenue. The Revenue has been growing by 22.22% on average per year.
EPS 1Y (TTM)-46.43%
EPS 3Y189.45%
EPS 5Y29.22%
EPS Q2Q%42.11%
Revenue 1Y (TTM)26.91%
Revenue growth 3Y24.3%
Revenue growth 5Y22.22%
Sales Q2Q%40.1%

3.2 Future

The Earnings Per Share is expected to grow by 19.11% on average over the next years. This is quite good.
Based on estimates for the next years, OPRA will show a quite strong growth in Revenue. The Revenue will grow by 16.87% on average per year.
EPS Next Y23.87%
EPS Next 2Y23.56%
EPS Next 3Y20.67%
EPS Next 5Y19.11%
Revenue Next Year21.95%
Revenue Next 2Y18.86%
Revenue Next 3Y17.81%
Revenue Next 5Y16.87%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
OPRA Yearly Revenue VS EstimatesOPRA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
OPRA Yearly EPS VS EstimatesOPRA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2 2.5

8

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 18.00 indicates a rather expensive valuation of OPRA.
83.69% of the companies in the same industry are more expensive than OPRA, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of OPRA to the average of the S&P500 Index (27.15), we can say OPRA is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 12.76, the valuation of OPRA can be described as correct.
89.01% of the companies in the same industry are more expensive than OPRA, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 21.60. OPRA is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 18
Fwd PE 12.76
OPRA Price Earnings VS Forward Price EarningsOPRA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

86.88% of the companies in the same industry are more expensive than OPRA, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, OPRA is valued cheaply inside the industry as 82.62% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 19.63
EV/EBITDA 13.98
OPRA Per share dataOPRA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

OPRA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of OPRA may justify a higher PE ratio.
A more expensive valuation may be justified as OPRA's earnings are expected to grow with 20.67% in the coming years.
PEG (NY)0.75
PEG (5Y)0.62
EPS Next 2Y23.56%
EPS Next 3Y20.67%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.18%, OPRA is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 16.20, OPRA pays a better dividend. On top of this OPRA pays more dividend than 98.58% of the companies listed in the same industry.
OPRA's Dividend Yield is rather good when compared to the S&P500 average which is at 2.42.
Industry RankSector Rank
Dividend Yield 4.18%

5.2 History

OPRA has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
OPRA Yearly Dividends per shareOPRA Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

74.76% of the earnings are spent on dividend by OPRA. This is not a sustainable payout ratio.
DP74.76%
EPS Next 2Y23.56%
EPS Next 3Y20.67%
OPRA Yearly Income VS Free CF VS DividendOPRA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M
OPRA Dividend Payout.OPRA Dividend Payout, showing the Payout Ratio.OPRA Dividend Payout.PayoutRetained Earnings

OPERA LTD-ADR

NASDAQ:OPRA (6/30/2025, 6:29:30 PM)

After market: 19.02 +0.12 (+0.63%)

18.9

+0.43 (+2.33%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)04-28 2025-04-28/bmo
Earnings (Next)08-20 2025-08-20/bmo
Inst Owners16.23%
Inst Owner Change15.97%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.69B
Analysts83.08
Price Target26.45 (39.95%)
Short Float %5.14%
Short Ratio4.28
Dividend
Industry RankSector Rank
Dividend Yield 4.18%
Yearly Dividend0.43
Dividend Growth(5Y)N/A
DP74.76%
Div Incr Years0
Div Non Decr Years0
Ex-Date01-06 2025-01-06 (0.4)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.55%
Min EPS beat(2)-3.68%
Max EPS beat(2)8.78%
EPS beat(4)3
Avg EPS beat(4)2.91%
Min EPS beat(4)-3.68%
Max EPS beat(4)8.78%
EPS beat(8)5
Avg EPS beat(8)62.12%
EPS beat(12)7
Avg EPS beat(12)35.69%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)5.11%
Min Revenue beat(2)3.71%
Max Revenue beat(2)6.51%
Revenue beat(4)3
Avg Revenue beat(4)2.41%
Min Revenue beat(4)-0.89%
Max Revenue beat(4)6.51%
Revenue beat(8)5
Avg Revenue beat(8)1.22%
Revenue beat(12)9
Avg Revenue beat(12)2%
Revenue beat(16)13
Avg Revenue beat(16)2.47%
PT rev (1m)0%
PT rev (3m)-0.82%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)2.21%
EPS NY rev (3m)2.26%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.13%
Revenue NY rev (1m)-0.21%
Revenue NY rev (3m)3.44%
Valuation
Industry RankSector Rank
PE 18
Fwd PE 12.76
P/S 3.23
P/FCF 19.63
P/OCF 18.82
P/B 1.82
P/tB 4.21
EV/EBITDA 13.98
EPS(TTM)1.05
EY5.56%
EPS(NY)1.48
Fwd EY7.84%
FCF(TTM)0.96
FCFY5.1%
OCF(TTM)1
OCFY5.31%
SpS5.85
BVpS10.39
TBVpS4.49
PEG (NY)0.75
PEG (5Y)0.62
Profitability
Industry RankSector Rank
ROA 8.07%
ROE 9.06%
ROCE 10.04%
ROIC 8.93%
ROICexc 10.03%
ROICexgc 27.08%
OM 18.07%
PM (TTM) 16.09%
GM 69.58%
FCFM 16.46%
ROA(3y)8.12%
ROA(5y)7.3%
ROE(3y)8.98%
ROE(5y)7.94%
ROIC(3y)6.4%
ROIC(5y)N/A
ROICexc(3y)7.3%
ROICexc(5y)N/A
ROICexgc(3y)20.62%
ROICexgc(5y)N/A
ROCE(3y)7.2%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y-12.55%
GM growth 3Y-8.45%
GM growth 5Y-5.94%
F-Score6
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.11
Debt/EBITDA 0.05
Cap/Depr 21.87%
Cap/Sales 0.71%
Interest Coverage 186.24
Cash Conversion 80.59%
Profit Quality 102.35%
Current Ratio 2.17
Quick Ratio 2.17
Altman-Z 10.43
F-Score6
WACC9.1%
ROIC/WACC0.98
Cap/Depr(3y)62.94%
Cap/Depr(5y)43.53%
Cap/Sales(3y)2.11%
Cap/Sales(5y)1.89%
Profit Quality(3y)170.05%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-46.43%
EPS 3Y189.45%
EPS 5Y29.22%
EPS Q2Q%42.11%
EPS Next Y23.87%
EPS Next 2Y23.56%
EPS Next 3Y20.67%
EPS Next 5Y19.11%
Revenue 1Y (TTM)26.91%
Revenue growth 3Y24.3%
Revenue growth 5Y22.22%
Sales Q2Q%40.1%
Revenue Next Year21.95%
Revenue Next 2Y18.86%
Revenue Next 3Y17.81%
Revenue Next 5Y16.87%
EBIT growth 1Y35.3%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year56.17%
EBIT Next 3Y29.61%
EBIT Next 5Y23.04%
FCF growth 1Y31.59%
FCF growth 3Y47.38%
FCF growth 5YN/A
OCF growth 1Y30.48%
OCF growth 3Y58.11%
OCF growth 5YN/A